Anhui Huaheng Biotechnology (688639.SS) Earnings Analysis
Anhui Huaheng Biotechnology (688639.SS) next reports earnings on 2026-08-25, consensus EPS 0.2505 CNY. Last quarter (2026-04-23) it missed with EPS 0.17 CNY vs 0.2505 CNY est (-32.1%). It has beaten estimates in 0/4 recent quarters (0%). Trailing P/E 32.46.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 688639.SS next report earnings?
| Next earnings date | 2026-08-25 |
|---|---|
| Consensus EPS estimate | 0.2505 CNY |
| Revenue estimate | 0.79B |
688639.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-23 | 0.17 CNY | 0.2505 CNY | -32.1% | Miss |
| 2026-02-28 | -0.38403 CNY | 0.02327 CNY | -1750.3% | Miss |
| 2025-10-27 | 0.2112 CNY | 0.4405 CNY | -52.1% | Miss |
| 2024-10-28 | 0.09 CNY | 0.72 CNY | -87.5% | Miss |
Beat rate: 0/4 (0%) over reported quarters with consensus data.
688639.SS valuation and analyst view
| Trailing P/E | 32.46 |
|---|---|
| Trailing EPS | 0.48801 CNY |
| Price / book | 1.51 |
| Dividend yield | 0.99% |
| Market cap | 4.00B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Anhui Huaheng Biotechnology (688639.SS)'s next earnings date?
Anhui Huaheng Biotechnology is next scheduled to report on 2026-08-25, with a consensus EPS estimate of 0.2505 CNY and revenue estimate of 0.79B.
Did 688639.SS beat earnings last quarter?
In its 2026-04-23 report, 688639.SS posted EPS of 0.17 CNY versus a 0.2505 CNY estimate — a miss of 32.1%.
What is 688639.SS's earnings track record?
Over the last 4 reported quarters with consensus data, 688639.SS beat estimates 0 times (0%).
What is 688639.SS's current P/E ratio and EPS?
688639.SS trades at a trailing P/E of 32.46 on trailing EPS of 0.4880121049073758 CNY.
What do analysts rate 688639.SS?
688639.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.